SMART
Live / Applied — Second extension granted (statement of use) (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 23 Sept 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97041678
- Mark type
- Stylized text
- Filed
- 23 Sept 2021
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for human use for the treatment of diseases, namely, pharmaceutical preparations for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
Prosecution history
- 05 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 2 GRANTED
- 04 Mar 2026 — SOU EXTENSION 2 FILED
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Oct 2025 — SOU EXTENSION 1 GRANTED
- 28 Oct 2025 — SOU EXTENSION 1 FILED
- 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Nov 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 08 Mar 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED